ReviewMolecular and clinical oncology2025
Immune cell involvement in ulcer repair in radiation esophagitis and its role in the TGF-β1/p38MAPK/FN axis (Review).
Review in Molecular and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present review explored the mechanism of the TGF-β1/p38MAPK/fibronectin (FN) signaling axis and immune cells during radiation esophagitis (RE) ulcer repair. A comprehensive analysis of the literature revealed that the TGF-β1/p38MAPK/FN signaling axis has a dual role in RE. Specifically, it initially promotes esophageal epithelial mucosal repair, but hyperactivation would then trigger tissue fibrosis. The intricate interplay between immune cells (macrophages, T cells and dendritic cells) and this signaling axis during the repair process of RE has been elucidated. Macrophages, in particular, serve a pivotal role in repair through polarization state switching. The influence of T-cell subpopulation differentiation and functional regulation on the immune response and tissue repair has also been demonstrated. By contrast, dendritic cells have been found to activate the immune response, though their function is repressed by TGF-β1. The complexity of RE's pathological process limits understanding into how the TGF-β1/p38MAPK/FN signaling axis precisely regulates immune cells at different repair stages, along with immune cells' properties and interactions. In the future, it is recommended that in-depth studies be conducted with the application of multi-omics and single-cell sequencing technologies, which are expected to contribute to the development of novel therapeutic strategies for RE and the advancement of RE clinical treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.